1. Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae. (3rd October 2022) Authors: Trum, M; Schollmeier, E; Riechel, J; Lebek, S; Reuthner, K; Keller, K; Wester, M; Provaznik, Z; Schmid, C; Maier, L; Arzt, M; Wagner, S Journal: European heart journal Issue: Volume 43(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗